ARTICLE | Company News
Roche, Celldex deal
April 13, 2015 7:00 AM UTC
The companies partnered to conduct a Phase I/II trial to evaluate Celldex’s varlilumab in combination with MPDL3280A from Roche to treat renal cell carcinoma (RCC). Celldex will conduct and fund the study, which will begin this year. ...